332 related articles for article (PubMed ID: 15877082)
21. Dendritic cells transfected with interleukin-12 and tumor-associated antigen messenger RNA induce high avidity cytotoxic T cells.
Bontkes HJ; Kramer D; Ruizendaal JJ; Kueter EW; van Tendeloo VF; Meijer CJ; Hooijberg E
Gene Ther; 2007 Feb; 14(4):366-75. PubMed ID: 17036057
[TBL] [Abstract][Full Text] [Related]
22. The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinoma.
Xu DP; Sauter BV; Huang TG; Meseck M; Woo SL; Chen SH
Gene Ther; 2005 Oct; 12(20):1526-33. PubMed ID: 15973445
[TBL] [Abstract][Full Text] [Related]
23. BCR-ABL is not an immunodominant antigen in chronic myelogenous leukemia.
Grünebach F; Mirakaj V; Mirakaj V; Müller MR; Brümmendorf T; Brossart P
Cancer Res; 2006 Jun; 66(11):5892-900. PubMed ID: 16740729
[TBL] [Abstract][Full Text] [Related]
24. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
25. Cancer immunotherapy with mRNA-transfected dendritic cells.
Gilboa E; Vieweg J
Immunol Rev; 2004 Jun; 199():251-63. PubMed ID: 15233739
[TBL] [Abstract][Full Text] [Related]
26. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.
Nair SK; Boczkowski D; Morse M; Cumming RI; Lyerly HK; Gilboa E
Nat Biotechnol; 1998 Apr; 16(4):364-9. PubMed ID: 9555728
[TBL] [Abstract][Full Text] [Related]
27. Induction of cytotoxic T lymphocytes against human cancer cell lines using dendritic cell-tumor cell hybrids generated by a newly developed electrofusion technique.
Imura K; Ueda Y; Hayashi T; Itoh T; Shimizu K; Tamai H; Yano Y; Naito K; Kohara J; Nakane K; Matsuura Y; Takeda A; Takeda T; Kawai K; Yamagishi H
Int J Oncol; 2006 Sep; 29(3):531-9. PubMed ID: 16865268
[TBL] [Abstract][Full Text] [Related]
28. Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses.
Bukczynski J; Wen T; Ellefsen K; Gauldie J; Watts TH
Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1291-6. PubMed ID: 14745033
[TBL] [Abstract][Full Text] [Related]
29. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
[TBL] [Abstract][Full Text] [Related]
30. Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes.
Grünebach F; Müller MR; Nencioni A; Brossart P
Gene Ther; 2003 Mar; 10(5):367-74. PubMed ID: 12601391
[TBL] [Abstract][Full Text] [Related]
31. Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy.
Fassnacht M; Lee J; Milazzo C; Boczkowski D; Su Z; Nair S; Gilboa E
Clin Cancer Res; 2005 Aug; 11(15):5566-71. PubMed ID: 16061874
[TBL] [Abstract][Full Text] [Related]
32. CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression.
Radford KJ; Turtle CJ; Kassianos AJ; Hart DN
J Immunother; 2006; 29(6):596-605. PubMed ID: 17063122
[TBL] [Abstract][Full Text] [Related]
33. Preparation of native and amplified tumour RNA for dendritic cell transfection and generation of in vitro anti-tumour CTL responses.
Bergant M; Meden L; Repnik U; Sojar V; Stanisavljević D; Jeras M
Immunobiology; 2006; 211(3):179-89. PubMed ID: 16530085
[TBL] [Abstract][Full Text] [Related]
34. Dendritic cell vaccine with mRNA targeted to the proteasome by polyubiquitination.
Hosoi A; Takeda Y; Sakuta K; Ueha S; Kurachi M; Kimura K; Maekawa R; Kakimi K
Biochem Biophys Res Commun; 2008 Jun; 371(2):242-6. PubMed ID: 18423376
[TBL] [Abstract][Full Text] [Related]
35. The combination of 4-1BBL and CD40L strongly enhances the capacity of dendritic cells to stimulate HIV-specific T cell responses.
De Keersmaecker B; Heirman C; Corthals J; Empsen C; van Grunsven LA; Allard SD; Pen J; Lacor P; Thielemans K; Aerts JL
J Leukoc Biol; 2011 Jun; 89(6):989-99. PubMed ID: 21427207
[TBL] [Abstract][Full Text] [Related]
36. Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes.
Strobel I; Berchtold S; Götze A; Schulze U; Schuler G; Steinkasserer A
Gene Ther; 2000 Dec; 7(23):2028-35. PubMed ID: 11175315
[TBL] [Abstract][Full Text] [Related]
37. Dendritic cell subsets generated from CD34+ hematopoietic progenitors can be transfected with mRNA and induce antigen-specific cytotoxic T cell responses.
Ueno H; Tcherepanova I; Reygrobellet O; Laughner E; Ventura C; Palucka AK; Banchereau J
J Immunol Methods; 2004 Feb; 285(2):171-80. PubMed ID: 14980432
[TBL] [Abstract][Full Text] [Related]
38. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
[TBL] [Abstract][Full Text] [Related]
39. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
[TBL] [Abstract][Full Text] [Related]
40. Depletion of CD25+ cells from human T-cell enriched fraction eliminates immunodominance during priming with dendritic cells genetically modified to express a secreted protein.
Mincheff M; Zoubak S; Altankova I; Tchakarov S; Pogribnyy P; Makogonenko Y; Botev C; Meryman HT
Cancer Gene Ther; 2005 Feb; 12(2):185-97. PubMed ID: 15375382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]